Seamount Financial Group’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$670K Hold
579
– – 0.26% 80
2026
Q2
$694K Hold
579
– – 0.28% 79
2026
Q1
$533K Hold
579
– – 0.24% 82
2025
Q4
$622K Buy
579
+4
+0.7% +$3.82K 0.28% 76
2025
Q3
$439K Buy
575
+225
+64% +$167K 0.21% 93
2025
Q2
$273K Buy
+350
New +$272K 0.14% 111

Other funds holding LLY

Seamount Financial Group's LLY Position: Q3 2026 in Review

Seamount Financial Group held its Eli Lilly (LLY) position steady in Q3 2026 at 579 shares worth $670K. The position accounts for 0.26% of the portfolio, ranked #80.

Seamount Financial Group first reported a position in LLY in Q2 2025 and has held it in 6 quarters since. The position peaked at $694K in Q2 2026. 3,638 funds tracked by Wall St. Rank hold LLY as of Q3 2026.

  • Seamount Financial Group held 579 shares of Eli Lilly worth $670K as of Q3 2026.
  • Seamount Financial Group left its Eli Lilly share count unchanged in Q3 2026.
  • Eli Lilly made up 0.26% of Seamount Financial Group's portfolio in Q3 2026, its #80 holding.
  • Seamount Financial Group first reported a position in Eli Lilly in Q2 2025 and has held it in 6 quarters since.
  • Seamount Financial Group's Eli Lilly position peaked at $694K in Q2 2026.
  • 3,638 funds tracked by Wall St. Rank held Eli Lilly as of Q3 2026.

Based on Seamount Financial Group's 13F filing for Q3 2026, filed 21 Oct 2026.